Camphor Seed Kernel Oil Beneficial Effects the Gut Microbiota of the Non-Alcoholic Fatty Liver Disease Mice

被引:4
|
作者
Wang, Baogui [1 ]
Wang, Jun [1 ]
Du, Wen [1 ]
Shang, Shuai [1 ]
机构
[1] Binzhou Univ, Coll Biol & Environm Engn, Binzhou 256600, Shandong, Peoples R China
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2022年 / 27卷 / 07期
关键词
non-alcoholic fatty liver disease; camphor seed kernel oil; intestinal microbiota; mice; LIPID-ACCUMULATION; OXIDATIVE STRESS; LONG-CHAIN; ACIDS; CELLS;
D O I
10.31083/j.fbl2707199
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Introduction: Non-alcoholic fatty liver disease (NAFLD) has become one of the most common liver diseases globally and its negative impact has grad- ually attracted attention. Method: In order to explore whether camphor seed oil has a certain link effect on NAFLD, we identified its remodeling of intestinal flora and liver function index through the use of camphor seed kernel oil as food treatment (CCSKO). Results: Our results showed that camphor seed oil significantly improved the liver index, TG content and histopathology of the NAFLD mice compared with other groups. Meanwhile, we found significant differences in the intestinal microbiota of mice in different treatment groups. Discussion: The CCSKO treatment might significantly increase the abundance of Bacteroidetes, which were involved in many important metabolic activities in the human colon, including carbohydrate fermentation, utilization of nitrogenous substances, and biotransformation of bile acids and other steroids. Conclusions: These findings indicate a strong contribution in shaping the gut microbiota by treatment groups, shedding light on the impact of camphor tree seed kernel oil on gut microbiota.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Gut microbiota and non-alcoholic fatty liver disease
    Gkolfakis, Paraskevas
    Dimitriadis, George
    Triantafyllou, Konstantinos
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (06) : 572 - 581
  • [2] Gut microbiota and non-alcoholic fatty liver disease
    Abenavoli, Ludovico
    Procopio, Anna C.
    Scarpellini, Emidio
    Polimeni, Natale
    Aquila, Isabella
    Larussa, Tiziana
    Boccuto, Luigi
    Luzza, Francesco
    MINERVA GASTROENTEROLOGY, 2021, 67 (04): : 339 - 347
  • [3] Gut microbiota and non-alcoholic fatty liver disease
    Paraskevas Gkolfakis
    George Dimitriadis
    Konstantinos Triantafyllou
    Hepatobiliary & Pancreatic Diseases International, 2015, 14 (06) : 572 - 581
  • [4] THE PATHOLOGICAL PROGRESSION OF NON-ALCOHOLIC FATTY LIVER DISEASE CORRELATES WITH GUT MICROBIOTA COMPOSITION IN MICE: FROM NON-ALCOHOLIC FATTY LIVER TO NON-ALCOHOLIC STEATOHEPATITIS
    Peng, J.
    Huang, F.
    Li, X.
    Chen, L.
    Feng, Q.
    Hu, Y.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S155 - S157
  • [5] Non-alcoholic fatty liver and the gut microbiota
    Bashiardes, Stavros
    Shapiro, Hagit
    Rozin, Shachar
    Shibolet, Oren
    Elinav, Eran
    MOLECULAR METABOLISM, 2016, 5 (09): : 782 - 794
  • [6] Hepatoprotective effects of Cassiae Semen on mice with non-alcoholic fatty liver disease based on gut microbiota
    Luo, Hanyan
    Wu, Hongwei
    Wang, Lixia
    Xiao, Shuiming
    Lu, Yaqi
    Liu, Cong
    Yu, Xiankuo
    Zhang, Xiao
    Wang, Zhuju
    Tang, Liying
    COMMUNICATIONS BIOLOGY, 2021, 4 (01)
  • [7] Hepatoprotective effects of Cassiae Semen on mice with non-alcoholic fatty liver disease based on gut microbiota
    Hanyan Luo
    Hongwei Wu
    Lixia Wang
    Shuiming Xiao
    Yaqi Lu
    Cong Liu
    Xiankuo Yu
    Xiao Zhang
    Zhuju Wang
    Liying Tang
    Communications Biology, 4
  • [8] Intestinal hormones, gut microbiota and non-alcoholic fatty liver disease
    Koukias, Nikolaos
    Buzzetti, Elena
    Tsochatzis, Emmanuel A.
    MINERVA ENDOCRINOLOGICA, 2017, 42 (02) : 184 - 194
  • [9] Gut microbiota and pediatric obesity/non-alcoholic fatty liver disease
    Yang, Yao-Jong
    Ni, Yen-Hsuan
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2019, 118 : S55 - S61
  • [10] Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease
    Zhou, Jin
    Tripathi, Madhulika
    Sinha, Rohit A.
    Singh, Brijesh Kumar
    Yen, Paul M.
    HEPATOMA RESEARCH, 2021, 7